IFP Advisors’s Pediatrix Medical MD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $62.6K | Sell |
2,472
-70
| -3% | -$1.59K | ﹤0.01% | 2259 |
|
|
2026
Q1 | $54.4K | Hold |
2,542
| – | – | ﹤0.01% | 2193 |
|
|
2025
Q4 | $54.4K | Sell |
2,542
-869
| -25% | -$17.8K | ﹤0.01% | 2151 |
|
|
2025
Q3 | $57.1K | Buy |
3,411
+44
| +1% | +$659 | ﹤0.01% | 2014 |
|
|
2025
Q2 | $49.5K | Sell |
3,367
-50
| -1% | -$686 | ﹤0.01% | 2058 |
|
|
2025
Q1 | $49.5K | Hold |
3,417
| – | – | ﹤0.01% | 1896 |
|
|
2024
Q4 | $44.8K | Buy |
3,417
+17
| +0.5% | +$235 | ﹤0.01% | 1879 |
|
|
2024
Q3 | $39.4K | Hold |
3,400
| – | – | ﹤0.01% | 1837 |
|
|
2024
Q2 | $25.7K | Sell |
3,400
-85
| -2% | -$703 | ﹤0.01% | 1965 |
|
|
2024
Q1 | $35K | Hold |
3,485
| – | – | ﹤0.01% | 1723 |
|
|
2023
Q4 | $32.4K | Hold |
3,485
| – | – | ﹤0.01% | 1726 |
|
|
2023
Q3 | $44.3K | Hold |
3,485
| – | – | ﹤0.01% | 1610 |
|
|
2023
Q2 | $49.5K | Hold |
3,485
| – | – | ﹤0.01% | 1609 |
|
|
2023
Q1 | $158K | Sell |
3,485
-2,893
| -45% | -$43.8K | 0.01% | 1044 |
|
|
2022
Q4 | $298K | Buy |
6,378
+2,253
| +55% | +$36.8K | 0.01% | 1145 |
|
|
2022
Q3 | $195K | Hold |
4,125
| – | – | 0.01% | 1415 |
|
|
2022
Q2 | $195K | Hold |
4,125
| – | – | 0.01% | 1296 |
|
|
2022
Q1 | $195K | Buy |
4,125
+13
| +0.3% | +$318 | 0.01% | 1296 |
|
|
2021
Q4 | $113K | Hold |
4,112
| – | – | ﹤0.01% | 1214 |
|
|
2021
Q3 | $118K | Hold |
4,112
| – | – | ﹤0.01% | 1213 |
|
|
2021
Q2 | $124K | Sell |
4,112
-1,359
| -25% | -$40.1K | ﹤0.01% | 1135 |
|
|
2021
Q1 | $138K | Hold |
5,471
| – | – | ﹤0.01% | 1010 |
|
|
2020
Q4 | $134K | Sell |
5,471
-337
| -6% | -$6.33K | 0.01% | 989 |
|
|
2020
Q3 | $95K | Hold |
5,808
| – | – | 0.01% | 1021 |
|
|
2020
Q2 | $96K | Buy |
5,808
+219
| +4% | +$3.25K | 0.01% | 943 |
|
|
2020
Q1 | $67K | Sell |
5,589
-143
| -2% | -$2.95K | 0.01% | 996 |
|
|
2019
Q4 | $156K | Hold |
5,732
| – | – | 0.01% | 755 |
|
|
2019
Q3 | $128K | Buy |
+5,732
| New | +$131K | 0.01% | 937 |
|
|
2019
Q1 | $1K | Buy |
50
+9
| +22% | +$302 | ﹤0.01% | 2232 |
|
|
2018
Q4 | $1K | Sell |
41
-8,573
| -100% | -$345K | ﹤0.01% | 3343 |
|
|
2018
Q3 | $402K | Buy |
8,614
+56
| +0.7% | +$2.57K | 0.02% | 767 |
|
|
2018
Q2 | $370K | Buy |
8,558
+8,442
| +7,278% | +$405K | 0.02% | 785 |
|
|
2018
Q1 | $6K | Hold |
116
| – | – | ﹤0.01% | 3081 |
|
|
2017
Q4 | $6K | Sell |
116
-631
| -84% | -$29.8K | ﹤0.01% | 3127 |
|
|
2017
Q3 | $32K | Sell |
747
-42
| -5% | -$2K | ﹤0.01% | 2298 |
|
|
2017
Q2 | $48K | Sell |
789
-70
| -8% | -$4.15K | ﹤0.01% | 1994 |
|
|
2017
Q1 | $60K | Hold |
859
| – | – | ﹤0.01% | 1817 |
|
|
2016
Q4 | $57K | Hold |
859
| – | – | ﹤0.01% | 1803 |
|
|
2016
Q3 | $57K | Sell |
859
-8,323
| -91% | -$569K | ﹤0.01% | 1728 |
|
|
2016
Q2 | $665K | Buy |
9,182
+9,132
| +18,264% | +$628K | 0.04% | 456 |
|
|
2016
Q1 | $1K | Sell |
50
-673
| -93% | -$44.6K | ﹤0.01% | 2221 |
|
|
2015
Q4 | $52K | Buy |
+723
| New | +$53.5K | ﹤0.01% | 1595 |
|
Other funds holding MD
WA
IFP Advisors's MD Position: Q2 2026 in Review
IFP Advisors reduced its Pediatrix Medical (MD) stake by 2.8% in Q2 2026, selling an estimated $1.59K and leaving 2,472 shares worth $62.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2259.
IFP Advisors first reported a position in MD in Q4 2015 and has held it in 42 quarters since. The position peaked at $665K in Q2 2016. 304 funds tracked by Wall St. Rank hold MD as of Q2 2026.
- IFP Advisors held 2,472 shares of Pediatrix Medical worth $62.6K as of Q2 2026.
- IFP Advisors sold 70 Pediatrix Medical shares in Q2 2026, an estimated $1.59K.
- Pediatrix Medical made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #2259 holding.
- IFP Advisors first reported a position in Pediatrix Medical in Q4 2015 and has held it in 42 quarters since.
- IFP Advisors's Pediatrix Medical position peaked at $665K in Q2 2016.
- 304 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2026.
Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.